April 30, 2025
The National Home Infusion Foundation (NHIF) welcomes the 2025-2026 Board of Directors. We’re honored to announce Melissa Leone, BSN, RN (CVS Health) as the new Chair and Todd Pledger BS, PharmD, RPh (Harbin Clinic LLC) as Vice-Chair. Joining them are new Board members: Dr. Femi Adewunmi, MD, MBA, CPE, SFHM (Option Care); Penny Allen (ret.); Brett Benfield (Fairview); Kristen McCloy, PharmD, BCSCP, IgCP (Kabafusion); and Jannifer Stoval, RN, BSN, MBA, CRNI, IgCN (Premier Infusion & Healthcare).
Thank you to our NHIF Board Members, whose dedication and expertise helps advance home and alternate site infusion care. Their commitment to our mission—fostering leadership, recognizing excellence, and promoting evidence-based research—strengthens our profession.
The National Home Infusion Association (NHIA) is releasing Infusion Industry Trends, the latest assessment of the home and alternate site infusion industry’s market position. Based on claims data from a 3-year timeframe, this focused analysis shows how the industry is evolving across therapy categories and payor environments.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2026. The authors of the following 4 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
The 2026 government funding for Health and Human Services that passed the House of Representatives today includes a change to the qualifying criteria for drugs under Medicare’s home infusion benefit that may expand access to certain health care provider-administered drugs if an infusion pump is required for administration. Passage of H.R. 4993, the Joe Fiandra Access to Home Infusion Act, reflects Congress’ recognition of the strong patient interest—including among individuals with rare diseases—in home infusion access.
